{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T07:19:17Z","timestamp":1771658357771,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.jacl.2009.02.009","type":"journal-article","created":{"date-parts":[[2009,2,17]],"date-time":"2009-02-17T20:42:50Z","timestamp":1234903370000},"page":"109-118","source":"Crossref","is-referenced-by-count":22,"title":["Efficacy and safety of combination therapy with niacin extended-release and simvastatin versus atorvastatin in\u00a0patients with dyslipidemia: The SUPREME Study"],"prefix":"10.1016","volume":"3","author":[{"suffix":"Jr.","given":"William","family":"Insull","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan N.","family":"Basile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony N.","family":"Vo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roopal","family":"Thakkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Padley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2009.02.009_bib1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2009.02.009_bib2","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2009.02.009_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","author":"Violi","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2009.02.009_bib4","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0002-9343(77)90874-9","article-title":"High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study","volume":"62","author":"Gordon","year":"1977","journal-title":"Am J Med"},{"key":"10.1016\/j.jacl.2009.02.009_bib5","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJMoa064278","article-title":"HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events","volume":"357","author":"Barter","year":"2007","journal-title":"N Engl J\u00a0Med."},{"key":"10.1016\/j.jacl.2009.02.009_bib6","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","article-title":"Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS\/TexCAPS. Air Force\/Texas Coronary Atherosclerosis Prevention Study","volume":"279","author":"Downs","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2009.02.009_bib7","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/jama.298.7.786","article-title":"High-density lipoprotein as a therapeutic target: a systematic review","volume":"298","author":"Singh","year":"2007","journal-title":"JAMA"},{"issue":"suppl","key":"10.1016\/j.jacl.2009.02.009_bib8","doi-asserted-by":"crossref","first-page":"3H","DOI":"10.1016\/0002-9149(92)91083-G","article-title":"Epidemiology of triglycerides: a view from Framingham","volume":"70","author":"Castelli","year":"1992","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.jacl.2009.02.009_bib9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00043798-199604000-00014","article-title":"Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies","volume":"3","author":"Hokanson","year":"1996","journal-title":"J\u00a0Cardiovasc Risk"},{"key":"10.1016\/j.jacl.2009.02.009_bib10","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/jama.276.7.544","article-title":"Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study","volume":"276","author":"Bostom","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2009.02.009_bib11","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1373\/clinchem.2006.079947","article-title":"Plasma lipoprotein(a) indicates risk for 4 distinct forms of vascular disease","volume":"53","author":"Jones","year":"2007","journal-title":"Clin Chem."},{"key":"10.1016\/j.jacl.2009.02.009_bib12","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1161\/01.CIR.102.16.1893","article-title":"Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the Prospective Pravastatin Pooling Project","volume":"102","author":"Sacks","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2009.02.009_bib13","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0735-1097(86)80293-5","article-title":"Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin","volume":"8","author":"Canner","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2009.02.009_bib14","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0955-2863(02)00284-X","article-title":"Niacin and cholesterol: role in\u00a0cardiovascular disease (review)","volume":"14","author":"Ganji","year":"2003","journal-title":"J Nutr Biochem"},{"issue":"suppl 6","key":"10.1016\/j.jacl.2009.02.009_bib15","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1185\/030079905X59094","article-title":"Beyond statin therapy: why we need new thinking","volume":"21","author":"Assmann","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jacl.2009.02.009_bib16","doi-asserted-by":"crossref","DOI":"10.1517\/14656566.8.13.2159","article-title":"Simvastatin: present and future perspectives","volume":"8","author":"Robinson","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jacl.2009.02.009_bib17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/MOL.0b013e3282364add","article-title":"Niacin in cardiovascular prevention: mechanisms, efficacy, and safety","volume":"18","author":"Guyton","year":"2007","journal-title":"Curr Opin Lipidol"},{"issue":"suppl 3","key":"10.1016\/j.jacl.2009.02.009_bib18","first-page":"I1","article-title":"Design, methods, and baseline results","volume":"47","year":"1973","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2009.02.009_bib19","unstructured":"Niaspan (package insert). Abbott Laboratories, North Chicago, IL, 2005."},{"key":"10.1016\/j.jacl.2009.02.009_bib20","unstructured":"Zocor (package insert). Merck, Sharp, & Dohme, LTD, Cramlington, Northumberland, UK, 2007."},{"key":"10.1016\/j.jacl.2009.02.009_bib21","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1056\/NEJMoa011090","article-title":"Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease","volume":"345","author":"Brown","year":"2001","journal-title":"N Engl J Med."},{"key":"10.1016\/j.jacl.2009.02.009_bib22","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1161\/01.CIR.0000148955.19792.8D","article-title":"Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins","volume":"110","author":"Taylor","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2009.02.009_bib23","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2009.02.009_bib24","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/00004872-200307000-00016","article-title":"Prospective, randomized, open-label, blinded-endpoint (PROBE) designed trials yield the same results as double-blind, placebo-controlled trials with respect to ABPM measurements","volume":"21","author":"Smith","year":"2003","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacl.2009.02.009_bib25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2165\/00129784-200808020-00001","article-title":"Long-term safety and efficacy of a combination of niacin extended release and simvastatin in patients with dyslipidemia: the OCEANS study","volume":"8","author":"Karas","year":"2008","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.jacl.2009.02.009_bib26","unstructured":"Simcor (package insert). Abbott Laboratories, North Chicago, IL, 2008."},{"key":"10.1016\/j.jacl.2009.02.009_bib27","unstructured":"Lipitor (package insert). Pfizer Ireland Pharmaceuticals, Dublin, Ireland, 2007."},{"key":"10.1016\/j.jacl.2009.02.009_bib28","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.amjcard.2008.02.092","article-title":"Comparison of the safety and efficacy of a combination tablet of niacin extended release and simvastatin vs simvastatin monotherapy in patients with increased non-HDL cholesterol (from the SEACOAST I study)","volume":"101","author":"Ballantyne","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2009.02.009_bib29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jacl.2008.02.004","article-title":"Comparison of the efficacy and safety of a combination tablet of niacin extended-release and simvastatin with simvastatin 80 mg monotherapy: the SEACOAST II (high-dose) study","volume":"2","author":"Ballantyne","year":"2008","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2009.02.009_bib30","unstructured":"Brinton EA, Vo A, Kashyap ML, Thakkar R, Padley RJ, Jiang P. Aspirin and a new formulation of niacin, extended-release, can reduce flushing incidence, duration, and severity. 2008 National Lipid Association Annual Scientific Congress, May 29\u2013June 1, 2008, Seattle, WA."}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287409000841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287409000841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T23:07:32Z","timestamp":1558134452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287409000841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S1933287409000841"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2009.02.009","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}